Compare USCB & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USCB | OFIX |
|---|---|---|
| Founded | 2002 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.1M | 481.0M |
| IPO Year | 2021 | 1998 |
| Metric | USCB | OFIX |
|---|---|---|
| Price | $21.92 | $9.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $24.35 | $13.00 |
| AVG Volume (30 Days) | 62.7K | ★ 320.6K |
| Earning Date | 10-22-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | 7.26 | ★ 29.39 |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | $25.22 | $3.48 |
| Revenue Next Year | $9.71 | $2.46 |
| P/E Ratio | $22.51 | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $16.36 | $8.50 |
| 52 Week High | $23.89 | $16.99 |
| Indicator | USCB | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 34.87 | 49.33 |
| Support Level | $17.83 | $9.13 |
| Resistance Level | $23.66 | $9.90 |
| Average True Range (ATR) | 0.45 | 0.39 |
| MACD | -0.18 | 0.12 |
| Stochastic Oscillator | 9.43 | 63.19 |
USCB Financial Holdings Inc is a bank holding company. Through its banking subsidiary, it offers relationship-based banking products, services, and solutions to a diverse set of clients in the local markets it operates in and international clients with U.S. banking needs. The Group's products and services offerings mainly include traditional deposit products, including commercial and consumer checking accounts, money market deposit accounts, savings accounts, etc.; e-banking services; title insurance policies for real estate transactions; and a variety of lending products such as small business loans, commercial real estate loans, business credit cards, etc.; and others. Geographically, its primary banking market is South Florida.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.